RIPK4

RIPK4 Full Name

receptor-interacting serine-threonine kinase 4

RIPK4 Introduction

RIPK4 (receptor-interacting serine/threonine kinase 4), also known as DIK or PKK, is a member of the receptor-interacting protein kinase family that governs inflammation, cell death, and differentiation. Unlike the better-known RIPK1 and RIPK3, which signal through death domains, RIPK4 is distinguished by a C-terminal array of ankyrin repeats, a domain composition that hints at roles in scaffolding and transcriptional control in addition to phosphorylation. The kinase is a central regulator of stratified epithelial biology: it coordinates keratinocyte differentiation, maintains the epidermal barrier, and is required for the proper development of the skin, oral mucosa, and palate. Loss-of-function mutations in RIPK4 cause Bartsocas-Papas syndrome, a severe autosomal recessive disorder characterized by extensive clefting, skin fusion, and other ectodermal anomalies, while milder heterozygous mutations produce popliteal pterygium syndrome. RIPK4 also integrates signals from protein kinase C and the IKK/NF-kB axis and has been implicated in the pathogenesis of oral, head and neck, and colorectal cancers, where its overexpression promotes invasion and metastasis. These dual roles in development and malignancy make RIPK4 an attractive subject for mechanistic study and a candidate drug target.

Figure 1. The structure of RIPK4.

Domain Organization and Kinase Signaling
The human RIPK4 gene is located on chromosome 21 and encodes a polypeptide of approximately 780 amino acids.
An N-terminal serine/threonine kinase domain is followed by an intermediate region and a C-terminal domain built from multiple ankyrin repeats, a configuration that allows RIPK4 to engage both catalytic substrates and protein-protein interaction partners.
Autophosphorylation within the activation segment is required for full kinase activity, and the enzyme can oligomerize through its C-terminal region to propagate signals.
In keratinocytes, RIPK4 is phosphorylated downstream of protein kinase C family members and in turn phosphorylates substrates such as IRF6, a transcription factor essential for epidermal and craniofacial development, thereby connecting PKC signaling to the IRF6-dependent differentiation program.
RIPK4 also activates the classical IKK complex and NF-kB transcription factors, and it has been reported to modulate JNK signaling in certain cellular settings.
The combination of kinase activity with ankyrin-repeat-mediated interactions allows RIPK4 to function both as an enzyme and as an adaptor, coupling extracellular cues to changes in gene expression that drive epithelial maturation.

Epithelial Development, Genetic Syndromes, and Cancer
During embryogenesis RIPK4 is expressed in the surface ectoderm, limb buds, and developing palate, where it promotes the differentiation of keratinocytes and the formation of the periderm, a transient protective layer essential for normal skin and palate development.
Biallelic loss-of-function mutations cause Bartsocas-Papas syndrome, whose hallmarks include severe orofacial clefting, fusion of the eyelids and gums, skin webs across joints, and syndactyly, reflecting failure of the RIPK4-IRF6 pathway.
Heterozygous mutations with dominant-negative effects give rise to the milder popliteal pterygium syndrome, demonstrating that RIPK4 activity is exquisitely dosage-sensitive during morphogenesis.
In adult tissues the kinase supports epidermal homeostasis, and its dysregulation perturbs the balance between proliferation and terminal differentiation.
In cancer, RIPK4 is overexpressed in oral squamous cell carcinoma and a subset of colorectal tumors, where it enhances tumor cell invasion, epithelial-mesenchymal transition, and metastatic spread, and elevated expression predicts worse clinical outcomes.
Small-molecule inhibitors of RIPK4 are being explored as a strategy to block its pro-tumorigenic signaling while leaving normal epithelial differentiation relatively intact.

Alternate Names for RIPK4

RIPK4; receptor-interacting serine-threonine kinase 4; ANKRD3, ankyrin repeat domain 3; receptor-interacting serine/threonine-protein kinase 4; ANKK2; DIK; PKC delta interacting protein kinase; PKK; protein kinase C associated kinase; RIP4